The recent reauthorization of the Patient-Centered Outcomes Research Institute (PCORI) comes with an expanded mandate to study the economic impacts of treatments presenting new opportunities for the value assessment research community.
T. Joseph Mattingly II, PhD, PharmD, MBA
Advertisement
Articles by T. Joseph Mattingly II, PhD, PharmD, MBA
Advertisement
Latest Updated Articles
PCORI’s Expanded Mandate Creates New Opportunities for Value Assessment ResearchPublished: July 29th 2021 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
Boosting RSV Vaccination in Older Adults Could Save Thousands
3
FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development
4
Real-World Data Key to Optimizing CAR T-Cell Therapy Delivery, Outcomes
5
